OA
MEDP icon

Oxbow Advisors’s Medpace MEDP Stock Holding History

Oxbow Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Buy
9,208
+7
+0.1% +$3.23K 0.4% 71
2026
Q1 		$4.42M Buy
9,201
+3
+0% +$1.54K 0.38% 70
2025
Q4 		$5.17M Sell
9,198
-79
-0.9% -$44.8K 0.45% 64
2025
Q3 		$4.77M Buy
9,277
+89
+1% +$38.9K 0.44% 62
2025
Q2 		$2.88M Buy
9,188
+323
+4% +$97K 0.32% 78
2025
Q1 		$2.7M Buy
+8,865
New +$2.98M 0.29% 74

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Oxbow Advisors's MEDP Position: Q2 2026 in Review

Oxbow Advisors increased its Medpace (MEDP) stake by 0.08% in Q2 2026, buying an estimated $3.23K and bringing the position to 9,208 shares worth $4.88M. The position accounts for 0.4% of the portfolio, ranked #71.

Oxbow Advisors first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.17M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Oxbow Advisors held 9,208 shares of Medpace worth $4.88M as of Q2 2026.
  • Oxbow Advisors bought 7 Medpace shares in Q2 2026, an estimated $3.23K.
  • Medpace made up 0.4% of Oxbow Advisors's portfolio in Q2 2026, its #71 holding.
  • Oxbow Advisors first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Oxbow Advisors's Medpace position peaked at $5.17M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Oxbow Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.